Seite wählen

AstraZeneca now also in China

MedImmune, an American biotechnology company arm of AstraZeneca since 2007, and WuXi AppTec, a leading research and development outsourcing comapny have established a joint venture in the Chinese market. The aim of the joint venture is the development and marketing of...